# Spero Therapeutics, Inc.: Form DEF 14A, filed Apr 16, 2024

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: DEF 14A
- Filed: 2024-04-16
- Accepted by EDGAR: Apr 16, 2024, 16:11 ET
- Period: 2024-05-29
- Accession: 0001193125-24-097749
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312524097749/d599560ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312524097749/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312524097749/d599560ddef14a.htm

Filed Apr 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-097749. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
